FDA Rolls Out Compounding Guidance, Seeks More Funding

Washington Drug Letter
Just days after the FDA’s new authorities over compounding pharmacies were signed into law, the agency last week issued draft guidances detailing how facilities register and report product information to the FDA.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00